BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12030541)

  • 1. The anabolic effects of parathyroid hormone.
    Rubin MR; Cosman F; Lindsay R; Bilezikian JP
    Osteoporos Int; 2002; 13(4):267-77. PubMed ID: 12030541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recombinant human parathyroid hormone--new perspectives for anabolic therapy of osteoporosis].
    Miazgowski T; Stefański A
    Pol Arch Med Wewn; 2004 Oct; 112(4):1249-54. PubMed ID: 15773439
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of osteoporosis in men.
    Orwoll ES
    Calcif Tissue Int; 2004 Aug; 75(2):114-9. PubMed ID: 15383924
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of primary hyperparathyroidism in the management of osteoporosis.
    Saleem TF; Horwith M; Stack BC
    Otolaryngol Clin North Am; 2004 Aug; 37(4):751-61, viii-ix. PubMed ID: 15262513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic effects of PTH and the 'anabolic window'.
    Pazianas M
    Trends Endocrinol Metab; 2015 Mar; 26(3):111-3. PubMed ID: 25662368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of parathyroid hormone in the management of osteoporosis.
    Rosen CJ
    Horm Res; 2005; 64 Suppl 2():81-5. PubMed ID: 16286779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parathyroid hormone -- its mechanisms of action and issues on clinical application].
    Okazaki R
    Clin Calcium; 2005 May; 15(5):845-51. PubMed ID: 15876749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic actions of parathyroid hormone on bone.
    Dempster DW; Cosman F; Parisien M; Shen V; Lindsay R
    Endocr Rev; 1993 Dec; 14(6):690-709. PubMed ID: 8119233
    [No Abstract]   [Full Text] [Related]  

  • 10. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of bone mineralization by parathyroid hormone].
    Shimizu M; Tamura T
    Clin Calcium; 2004 Jun; 14(6):70-5. PubMed ID: 15577058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
    Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
    J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone as a therapeutic agent.
    Mitlak BH
    Curr Opin Pharmacol; 2002 Dec; 2(6):694-9. PubMed ID: 12482733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of bone loss and gain in untreated and treated osteoporosis.
    Compston J
    Endocrine; 2002 Feb; 17(1):21-7. PubMed ID: 12014699
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid hormone and periosteal bone expansion.
    Parfitt AM
    J Bone Miner Res; 2002 Oct; 17(10):1741-3. PubMed ID: 12369776
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of osteoanabolic therapy: a decade of experience.
    Cipriani C; Irani D; Bilezikian JP
    J Bone Miner Res; 2012 Dec; 27(12):2419-28. PubMed ID: 23165426
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone - a bone anabolic and catabolic agent.
    Poole KE; Reeve J
    Curr Opin Pharmacol; 2005 Dec; 5(6):612-7. PubMed ID: 16181808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in designing and testing a "cure" for osteoporosis.
    Cummings S
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary hyperparathyroidism: pathophysiology and impact on bone.
    Khan A; Bilezikian J
    CMAJ; 2000 Jul; 163(2):184-7. PubMed ID: 10934983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.